US Stock MarketDetailed Quotes
ENZ Enzo Biochem
- 1.080
- +0.050+4.85%
Close Nov 29 13:00 ET
- 1.080
- 0.0000.00%
Post 17:01 ET
56.42MMarket Cap-2117P/E (TTM)
1.100High1.010Low203.02KVolume1.010Open1.030Pre Close220.18KTurnover0.58%Turnover RatioLossP/E (Static)52.24MShares1.36852wk High1.01P/B37.84MFloat Cap0.90352wk Low--Dividend TTM35.04MShs Float104.324Historical High--Div YieldTTM8.74%Amplitude0.903Historical Low1.084Avg Price1Lot Size
Enzo Biochem Key Stats
Quarterly+Annual
YOY
| (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.72%31.91M | -16.00%7.53M | 7.17%8.02M | 13.83%8.55M | 9.90%7.81M | -4.85%31.06M | 116.55%8.96M | -71.46%7.49M | -77.93%7.51M | -73.22%7.1M |
| Operating revenue | 2.72%31.91M | -16.00%7.53M | 7.17%8.02M | 13.83%8.55M | 9.90%7.81M | -4.85%31.06M | 116.55%8.96M | -71.46%7.49M | -77.93%7.51M | -73.22%7.1M |
| Cost of revenue | -11.39%17.28M | -25.94%4.31M | -4.18%4.29M | -6.22%4.33M | -5.19%4.35M | 1.47%19.5M | 119.41%5.81M | -72.11%4.48M | -74.12%4.62M | -69.95%4.59M |
| Gross profit | 26.51%14.63M | 2.38%3.22M | 24.06%3.73M | 45.76%4.22M | 37.43%3.46M | -13.88%11.57M | 113.00%3.15M | -70.42%3.01M | -82.12%2.9M | -77.65%2.51M |
| Operating expense | -25.63%27M | -49.07%8.41M | -28.35%5.08M | -13.84%5.65M | 28.03%7.86M | 42.24%36.3M | 216.84%16.52M | -43.57%7.1M | -57.12%6.56M | -47.98%6.14M |
| Selling and administrative expenses | -24.83%24.36M | -49.05%7.81M | -27.90%4.48M | -6.67%5.07M | 28.88%7.01M | 40.35%32.4M | 210.41%15.32M | -45.71%6.21M | -62.46%5.43M | -50.81%5.44M |
| -General and administrative expense | -24.83%24.36M | -49.05%7.81M | -27.90%4.48M | -6.67%5.07M | 28.88%7.01M | 40.35%32.4M | --15.32M | --6.21M | --5.43M | -50.81%5.44M |
| Research and development costs | -32.33%2.64M | -49.25%607K | -31.56%605K | -48.44%580K | 21.46%849K | 60.13%3.9M | 561.78%1.2M | -21.98%884K | 37.20%1.13M | -6.05%699K |
| Operating profit | 50.01%-12.37M | 61.17%-5.19M | 66.94%-1.35M | 61.06%-1.42M | -21.51%-4.4M | -104.57%-24.74M | -32.89%-13.37M | -70.15%-4.09M | -496.64%-3.66M | -558.55%-3.62M |
| Net non-operating interest income expense | 397.77%3.34M | 161.10%746K | 2,116.67%726K | 1,317.46%893K | 1,256.94%977K | -730.34%-1.12M | -7,282.35%-1.22M | -166.67%-36K | -7.35%63K | 84.62%72K |
| Non-operating interest income | 1,177.26%3.54M | ---- | ---- | ---- | ---- | 55.62%277K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -85.92%197K | ---- | ---- | ---- | ---- | --1.4M | ---- | ---- | ---- | ---- |
| Total other finance cost | ---- | ---- | -2,116.67%-726K | -1,317.46%-893K | -1,256.94%-977K | ---- | ---- | 166.67%36K | 7.35%-63K | -84.62%-72K |
| Other net income (expense) | -194.86%-793K | -42.26%3.3M | 60.10%-1.51M | -147.29%-332K | -24.78%-2.25M | 109.92%836K | 1,325.75%5.71M | -50.60%-3.77M | 119.26%702K | 0.22%-1.8M |
| Gain on sale of security | -382.24%-1.29M | 214.84%650K | -361.67%-908K | -78.94%310K | -67.38%-1.33M | 120.52%456K | -68.96%-566K | 132.86%347K | 427.11%1.47M | -109.19%-797K |
| Special income (charges) | ---- | ---- | 83.77%-692K | 14.30%-761K | -6.75%-1.08M | ---- | ---- | -481.06%-4.27M | 68.79%-888K | 21.45%-1.01M |
| -Less:Other special charges | ---- | ---- | -83.77%692K | -14.30%761K | 6.75%1.08M | ---- | ---- | 481.06%4.27M | -68.79%888K | -21.45%1.01M |
| Other non- operating income (expenses) | 30.00%494K | 2.54%121K | -34.72%94K | 0.85%119K | --158K | 129.97%380K | 307.02%118K | 120.11%144K | 133.71%118K | ---- |
| Income before tax | 60.77%-9.82M | 87.07%-1.15M | 73.02%-2.13M | 70.16%-863K | -6.00%-5.68M | -23.02%-25.02M | 15.52%-8.88M | -62.69%-7.9M | -8.93%-2.89M | -130.88%-5.35M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -228.54%-26.08M | -123.30%-13.38M | 80.11%-3.02M | 72.96%-3.06M | 37.79%-6.62M | 211.10%20.29M | 781.02%57.43M | -212.88%-15.19M | -326.37%-11.32M | -358.60%-10.64M |
| Net income continuous Operations | 60.77%-9.82M | 87.07%-1.15M | 73.02%-2.13M | 70.16%-863K | -6.00%-5.68M | -23.02%-25.02M | 15.52%-8.88M | -62.69%-7.9M | -8.93%-2.89M | -130.88%-5.35M |
| Net income discontinuous operations | -135.89%-16.26M | -118.45%-12.23M | 87.81%-889K | 73.92%-2.2M | 82.18%-941K | 2,080.46%45.31M | --66.31M | ---7.29M | ---8.43M | ---5.28M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -228.54%-26.08M | -123.30%-13.38M | 80.11%-3.02M | 72.96%-3.06M | 37.79%-6.62M | 211.10%20.29M | 781.02%57.43M | -212.88%-15.19M | -326.37%-11.32M | -358.60%-10.64M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -228.54%-26.08M | -123.30%-13.38M | 80.11%-3.02M | 72.96%-3.06M | 37.79%-6.62M | 211.10%20.29M | 781.02%57.43M | -212.88%-15.19M | -326.37%-11.32M | -358.60%-10.64M |
| Basic earnings per share | -224.39%-0.51 | -122.22%-0.26 | 80.65%-0.06 | 73.91%-0.06 | 40.91%-0.13 | 207.89%0.41 | 750.00%1.17 | -210.00%-0.31 | -360.00%-0.23 | -340.00%-0.22 |
| Diluted earnings per share | -224.39%-0.51 | -122.22%-0.26 | 80.65%-0.06 | 73.91%-0.06 | 40.91%-0.13 | 207.89%0.41 | 750.00%1.17 | -210.00%-0.31 | -360.00%-0.23 | -340.00%-0.22 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data